Clinical trial
A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In…
NCT00267267 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00267267 |
|---|---|
| Title | A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. |
| Official title | Phase 3, Open-Label, Multi-Center, Double-Blind, Randomized, Parallel Group Study Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin, Administered Once Daily (QD) Compared to Fixed Combination Ezetimibe/Simvastatin for 6 Weeks in Subjects With Dyslipidemia. |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia, Dyslipidemia |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, ezetimibe/simvastatin |
| Enrollment | 1,784 |
| Start date | Jan 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Dec 20, 2005 |
| Last update posted | Dec 10, 2007 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: